Xenon Pharmaceuticals (XENE)

• Market cap: $3.17B
• 1 day: -1.8%
• 5 days: -0.65%
• 1 month: -7.05%
• 3 months: -3.89%
• 6 months: 33.28%
• Year to date: -7.82%
• 1 year: 1.33%
• 5 years: 163.73%
• 10 years: 514.84%
• Sector: Healthcare
• Industry: Biotechnology

About: Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Employees: 327